C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index (original) (raw)

References

1. Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motojy T, Omoto E, Saito H, Ohno R, Ueda R . Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074–3080.
   CAS PubMed Google Scholar
2. Schnittger S, Schoh C, Dugas M, Kern W, Staib P, Wuchter C, Loffler H, Sauerland CM, Serve H, Buchner T, Haferlach T, Hiddeman . Analysis of FLT3 length mutation in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100: 59–66.
   Article CAS PubMed Google Scholar
3. Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, Wermke M, Bornhauser M, Ritter M, Neubauer A, Ehninger G, Illmer T . Analysis of FLT3-activating mutation in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of a sugroups with poor prognosis. Blood 2002; 99: 4326–4335.
   Article CAS PubMed Google Scholar
4. Beghini A, Cairoli R, Morra E, Larizza L . In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent c-kit mutation. Blood Cells Mol Dis 1998; 24: 262–270.
   Article CAS PubMed Google Scholar
5. Beghini A, Larizza L, Cairoli R, Morra E . c-kit activating mutations and mast cell proliferation in human leukemia. Blood 1998; 92: 701–702.
   CAS PubMed Google Scholar
6. Beghini A, Peterlongo P, Ripamonti CB, Larizza L, Cairoli R, Morr E, Mecucci C . C-kit mutations in core binding factor leukemias. Blood 2000; 95: 726–727.
   CAS PubMed Google Scholar
7. Gari M, Goodeve A, Wilson G, Winship P, Langabeer S, Linch D, Vandeberghe E, Peake I, Reilly J . c-kit proto-oncogene exone 8 in-frame deletion plus insertion mutation in acute myeloid leukemia. Br J Haematol 1999; 105: 894–900.
   Article CAS PubMed Google Scholar
8. Nguyen S, Leblanc T, Fenaux P, Witz F, Blaise D, Pigneux A, Thom X, Rigal-Huguet F, Lioure B, Auvrignon A, Fiere D, Reiffers J, Castaigne S, Leverger G, Harousseau Jl, Socie G, Dombret H . A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML intergroup. Blood 2002; 99: 3517–3523.
   Article CAS PubMed Google Scholar
9. Schlenk RF, Dohner H, Pforsich M, Benner A, Fischer K, Hartmann F, Fischer JT, Weber W, Gunzer U, Pralle H, Has R . Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone. Br J Haematol 1997; 99: 386–393.
   Article CAS PubMed Google Scholar

Download references